VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 181 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $100,000 | -40.1% | 10,100 | -34.3% | 0.00% | – |
| Q2 2022 | $167,000 | -37.7% | 15,372 | -35.2% | 0.00% | – |
| Q1 2022 | $268,000 | -15.7% | 23,704 | +16.8% | 0.00% | -100.0% |
| Q4 2021 | $318,000 | -73.6% | 20,300 | -71.1% | 0.00% | -75.0% |
| Q3 2021 | $1,203,000 | +158.7% | 70,139 | +224.5% | 0.00% | +100.0% |
| Q2 2021 | $465,000 | +72.9% | 21,617 | +31.9% | 0.00% | 0.0% |
| Q4 2019 | $269,000 | -57.4% | 16,388 | -32.2% | 0.00% | -60.0% |
| Q4 2018 | $632,000 | +229.2% | 24,180 | +187.9% | 0.01% | +400.0% |
| Q3 2018 | $192,000 | -86.8% | 8,400 | -91.2% | 0.00% | -85.7% |
| Q4 2017 | $1,453,000 | +24116.7% | 95,500 | +23775.0% | 0.01% | – |
| Q1 2017 | $6,000 | -98.8% | 400 | -98.8% | 0.00% | -100.0% |
| Q4 2016 | $510,000 | +7185.7% | 32,000 | +7900.0% | 0.00% | – |
| Q3 2016 | $7,000 | -81.6% | 400 | -91.1% | 0.00% | – |
| Q1 2016 | $38,000 | – | 4,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |